Krsnaa Diagnostics Ltd is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services and is all set to make a debut in the stock market with IPO of issue size of 1213.33 Cr.
Krsnaa Diagnostics Limited IPO –Overview
|Krsnaa Diagnostics Limited IPO Issue Date||4- 6 August 2021|
|Krsnaa Diagnostics Limited IPO Opening Date||6 August 2021|
|Krsnaa Diagnostics Limited IPO Face Value||INR 5 per share|
|Krsnaa Diagnostics Limited IPO Price||INR 954 per share|
|Krsnaa Diagnostics Limited IPO Lot Size||15 Shares|
|Issue Size||1,213.33 Cr|
|Offer for sale||813.33 Cr|
|Issue Type||Book built Issue IPO|
|Listing At||BSE, NSE|
|QIB Shares Offered||49.83 times|
|NII (HNI) Shares||116.30 times|
|Company Promoters||Rajendra Mutha is the promoter of the company.|
Krsnaa Diagnostics Limited IPO-Tentative Dates
|Krsnaa Diagnostics Limited IPO opening date||4 August 2021|
|Krsnaa Diagnostics Limited IPO closing date||6 August 2021|
|Basis of Allotment||11 August 2021|
|Initiation of Refunds||12 August 2021|
|The credit of Shares to Demat||13 August 2021|
|Krsnaa Diagnostics Limited IPO Listing Date||16 August 2021|
Krsnaa Diagnostics – Industry Overview.
The Indian diagnostic industry has grown consistently over the past three fiscals and is projected to grow at a CAGR of approximately 15% between fiscals 2021 and 2023The size of the diagnostic industry is estimated to be approximately ₹ 710 billion to ₹ 730 billion in Fiscal 2021, registering a healthy CAGR of 13% to 14%, echoing the growth from healthcare delivery services, over Fiscal 2017’s industry size of approximately ₹ 472 billion. The industry is expected to grow at approximately 15% and achieve a value of ₹ 920 billion to ₹ 980 billion in Fiscal 2023.
Krsnaa Diagnostics Limited IPO – Company Overview
Krsnaa Diagnostics is a large and differentiated diagnostic service provider. also provide a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory, and teleradiology services to public and private hospitals, medical colleges, and community health centres pan-India. the fastest growing diagnostic chain in India on multiple parameters including operating income, operating profit before depreciation, interest, and tax (“OPBDIT”) and profit after tax between Fiscal 2017 and Fiscal 2020, and volume of tests conducted between Fiscal 2018 and Fiscal 2020 (amongst players with revenues exceeding ₹1,500 million). According to CRISIL Report, also operate one of India’s largest teleradiology reporting hubs in Pune that can process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year and allows us to serve patients in remote locations where diagnostic facilities are limited. provide quality and inclusive diagnostic services at affordable rates across various segments.
Krsnaa Diagnostics Limited IPO-Objectives
- To finance the cost of establishing diagnostics centers in Punjab, Karnataka, Himachal Pradesh, and Maharashtra.
- Repayment/pre-payment of firm’s borrowings fully or partially.
- general corporate purposes.
Krsnaa Diagnostics Limited IPO – Financial Statements
|Profit After Tax||1,849.29||1,119.51||580.57|
Krsnaa Diagnostics Limited IPO Strengths
- Differentiated diagnostic service provider company in India.
- A comprehensive range of diagnostic services.
- Strong brand equity with quality healthcare services at affordable prices.
- Extensive market footprint in 13 states across India.
- Consistent financial performance track record.
Krsnaa Diagnostics Limited IPO Weakness
- Significant dependence on payments under contact with public health agencies.
- Any failure to comply with the legal and regulatory requirements.
Company Contact Information
Krsnaa Diagnostics Limited
S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1,
Chinchwad, Taluka – Haveli, Pune – 411 019
Phone: +91 20 4695 4695
Krsnaa Diagnostics IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Krsnaa Diagnostics IPO Lead Manager
- DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd
- Equirus Capital Private Limited
- IIFL Securities Ltd